From: Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial
Total gel applicators
Total evaluable applicators
Total number of applicators vaginally inserted
Total number of applicators NOT vaginally inserted
1246 (100%)
1098 (88%)
881 (80%)
217 (20%)